GEICO1601-ROLANDO: A multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer

  1. Perez-Fidalgo, J.A.
  2. Iglesias, M.
  3. Bohn, U.
  4. Calvo, E.
  5. Garcia, Y.
  6. Guerra, E.
  7. Manso, L.
  8. Santaballa, A.
  9. Gonzalez-Martin, A.
Journal:
Future Science OA

ISSN: 2056-5623

Year of publication: 2019

Volume: 5

Issue: 2

Type: Article

DOI: 10.4155/FSOA-2018-0107 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals